Your browser doesn't support javascript.
loading
Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.
Hui, Rina; Pearson, Alex; Cortes, Javier; Campbell, Christine; Poirot, Camille; Azim, Hatem A; Fumagalli, Debora; Lambertini, Matteo; Daly, Fergus; Arahmani, Amal; Perez-Garcia, José; Aftimos, Philippe; Bedard, Philippe L; Xuereb, Laura; Scheepers, Elsemieke D; Vicente, Malou; Goulioti, Theodora; Loibl, Sibylle; Loi, Sherene; Pierrat, Marie-Jeanne; Turner, Nicholas C; Andre, Fabrice; Curigliano, Giuseppe.
Afiliação
  • Hui R; Westmead Hospital and the University of Sydney, New South Wales, Australia. rina.hui@sydney.edu.au.
  • Pearson A; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Cortes J; IOB Institute of Oncology, Quironsalud Groups, Madrid and Barcelona and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Campbell C; Frontier Science (Scotland), United Kingdom.
  • Poirot C; Institut de Recherches Internationales Servier, Suresnes, France.
  • Azim HA; Institut Jules Bordet, Brussels, Belgium.
  • Fumagalli D; Breast International Group, Brussels, Belgium.
  • Lambertini M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Daly F; IRCCS Ospedale Policlinico San Martino and University of Genova, Genova, Italy.
  • Arahmani A; Frontier Science (Scotland), United Kingdom.
  • Perez-Garcia J; Breast International Group, Brussels, Belgium.
  • Aftimos P; Vall d'Hebron Institute of Oncology (VHIO) Barcelona, and IOB Institute of Oncology, Grupo Quironsalud, Madrid and Barcelona, Spain.
  • Bedard PL; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Xuereb L; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Scheepers ED; Institut de Recherches Internationales Servier, Suresnes, France.
  • Vicente M; Frontier Science (Scotland), United Kingdom.
  • Goulioti T; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Loibl S; Breast International Group, Brussels, Belgium.
  • Loi S; German Breast Group, Neu-Isenburg, Germany.
  • Pierrat MJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Turner NC; Institut de Recherches Internationales Servier, Suresnes, France.
  • Andre F; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Curigliano G; Institut de Cancerologie Gustave Roussy, Villejuif, France.
Clin Cancer Res ; 26(2): 354-363, 2020 01 15.
Article em En | MEDLINE | ID: mdl-31619444
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Receptores de Progesterona / Biomarcadores Tumorais / Receptor ErbB-2 / Receptor alfa de Estrogênio / Naftalenos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Receptores de Progesterona / Biomarcadores Tumorais / Receptor ErbB-2 / Receptor alfa de Estrogênio / Naftalenos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos